Cargando…

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis

Detalles Bibliográficos
Autores principales: Di Filippo, Massimiliano, Gaetani, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477698/
https://www.ncbi.nlm.nih.gov/pubmed/36128013
http://dx.doi.org/10.1016/j.lanepe.2022.100512
_version_ 1784790420891369472
author Di Filippo, Massimiliano
Gaetani, Lorenzo
author_facet Di Filippo, Massimiliano
Gaetani, Lorenzo
author_sort Di Filippo, Massimiliano
collection PubMed
description
format Online
Article
Text
id pubmed-9477698
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94776982022-09-16 SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis Di Filippo, Massimiliano Gaetani, Lorenzo Lancet Reg Health Eur Comment Elsevier 2022-09-16 /pmc/articles/PMC9477698/ /pubmed/36128013 http://dx.doi.org/10.1016/j.lanepe.2022.100512 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Comment
Di Filippo, Massimiliano
Gaetani, Lorenzo
SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
title SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
title_full SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
title_fullStr SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
title_full_unstemmed SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
title_short SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
title_sort sars-cov-2 vaccines tolerability: a perspective by people with multiple sclerosis
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477698/
https://www.ncbi.nlm.nih.gov/pubmed/36128013
http://dx.doi.org/10.1016/j.lanepe.2022.100512
work_keys_str_mv AT difilippomassimiliano sarscov2vaccinestolerabilityaperspectivebypeoplewithmultiplesclerosis
AT gaetanilorenzo sarscov2vaccinestolerabilityaperspectivebypeoplewithmultiplesclerosis